HYPOPROTHROMBINEMIA IN CHILDHOOD SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:43
|
作者
EBERHARD, A
SPARLING, C
SUDBURY, S
FORD, P
LAXER, R
SILVERMAN, E
机构
[1] UNIV TORONTO, HOSP SICK CHILDREN,DEPT PEDIAT,DIV RHEUMATOL, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA
[2] UNIV TORONTO, HOSP SICK CHILDREN, DEPT PEDIAT, DIV HEMATOL, TORONTO M5G 1X8, ONTARIO, CANADA
[3] QUEENS UNIV, DEPT MED, DIV RHEUMATOL, KINGSTON K7L 3N6, ONTARIO, CANADA
关键词
FACTOR-II; LUPUS ANTICOAGULANT; HYPOTHROMBINEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS;
D O I
10.1016/0049-0172(94)90095-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three children with systemic lupus erythematosus who developed hemorrhagic tendencies as a consequence of a clotting factor II (prothrombin) deficiency are described. All three responded rapidly to treatment with corticosteroids. A literature review added 25 case reports, with the following findings. First, factor II deficiency occurs in the presence of the lupus anticoagulant, although the interrelationship between the two is not understood. Second, the deficiency is presumed to be secondary to rapid clearing of the antigen/antibody factor II complex in the liver. Finally, most cases respond to corticosteroid therapy with or without the coadministration of vitamin K or fresh frozen plasma. In corticosteroid-dependent patients, the addition of antimetabolites such as azathioprine has enabled reduction in steroid doses. © 1994.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [31] A CASE OF BULLOUS SYSTEMIC LUPUS-ERYTHEMATOSUS
    SHIRAHAMA, S
    YAGI, H
    FURUKAWA, F
    TAKIGAWA, M
    DERMATOLOGY, 1994, 189 : 95 - 96
  • [32] AMICROBIAL PUSTULOSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    OBERLIN, P
    BAGOT, M
    PERRUSSEL, M
    LETEINTURIER, F
    WECHSLER, J
    REVUZ, J
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1991, 118 (11): : 824 - 825
  • [33] SUBRETINAL NEOVASCULARIZATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DREYER, EB
    MORGAN, CM
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1991, 26 (03): : 159 - 160
  • [34] MONOCLONAL GAMMOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    PORCEL, JM
    ORDI, J
    TOLOSA, C
    SELVA, A
    CASTROSALOMO, A
    VILARDELL, M
    LUPUS, 1992, 1 (04) : 263 - 264
  • [35] LABORATORY DIAGNOSIS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    HILLIQUIN, P
    WEILL, BJ
    ANNALES DE MEDECINE INTERNE, 1991, 142 (07): : 515 - 520
  • [36] CYTOKINES IN THE PATHOPHYSIOLOGY OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    GOLDMAN, M
    AUTOIMMUNITY, 1990, 8 (02) : 173 - 179
  • [37] LIPOPROTEIN(A) LEVELS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BORBA, EF
    SANTOS, RD
    BONFA, E
    VINAGRE, CG
    PILEGGI, FJC
    COSSERMELLI, W
    MARANHAO, RC
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (02) : 220 - 223
  • [38] ANTIPHOSPHATIDYLETHANOLAMINE ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    KARMOCHKINE, M
    BERARD, M
    PIETTE, JC
    CACOUB, P
    AILLAUD, MF
    HARLET, JR
    GODEAU, P
    BOFFA, MC
    LUPUS, 1993, 2 (03) : 157 - 160
  • [39] SECONDARY ERYTHERMALGIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DRENTH, JPH
    MICHIELS, JJ
    VANJOOST, T
    VUZEVSKI, VD
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (01) : 144 - 146
  • [40] PROGNOSTIC FACTORS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SWAAK, AJG
    NOSSENT, JC
    SMEENK, RJT
    RHEUMATOLOGY INTERNATIONAL, 1991, 11 (03) : 127 - 132